Maldi-imaging for proteomics of protease inhibitors
J. Bromsoms, Stephen J. Trejo, Jana Alonso Lorenzo, Patricia Marín‐García, José M. Bautista, Francesc Avilés
Abstract
J. Bromsoms, Stephen J. Trejo, Jana Alonso Lorenzo, Patricia Marín‐García, José M. Bautista, Francesc Avilés
Abstract
MALDI-imaging mass spectrometry (MALDI-IMS) is a novel experimental approach to visualize the distribution of biomolecules on tissue sections [1]. Proteins, peptides, lipids and metabolites can be analyzed in a selective and/or highthroughput manner. The application of IMS allows acquisition of protein and peptide profiles, biomarker discovery, biomarker localization, tissue classification or cancer diagnosis and prognosis [1,2]. In this study we report the distribution of protease inhibitors in several mouse tissues, after intraperitoneal injection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
MALDI-imaging mass spectrometry (MALDI-IMS) is a novel experimental approach to visualize the distribution of biomolecules on tissue sections [1]. Proteins, peptides, lipids and metabolites can be analyzed in a selective and/or highthroughput manner. The application of IMS allows acquisition of protein and peptide profiles, biomarker discovery, biomarker localization, tissue classification or cancer diagnosis and prognosis [1,2]. In this study we report the distribution of protease inhibitors in several mouse tissues, after intraperitoneal injection.
Key concepts: Proteomics, Protease, Biomarker discovery, Biomarker, Mass spectrometry imaging, Chemistry, Biomolecule, Peptide